CLINICAL_TRIALS
trial_result
· 2021-02-09
Clinical Trial Update: HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer [Phase 2]
Summary
A Phase 2 clinical trial comparing HDR brachytherapy to LDR brachytherapy as monotherapy for localized prostate cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: CHU de Quebec-Universite Laval | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED